6.10Open8.65Pre Close51 Volume120 Open Interest104.00Strike Price31.11KTurnover140.73%IV1.41%PremiumDec 13, 2024Expiry Date4.61Intrinsic Value100Multiplier1DDays to Expiry1.53Extrinsic Value100Contract SizeAmericanOptions Type0.7507Delta0.0432Gamma18.89Leverage Ratio-1.4124Theta0.0017Rho14.18Eff Leverage0.0166Vega
Novo-Nordisk A/S Stock Discussion
FLOW trial evaluated the risk reduction associated with treatment with Ozempic ® in chronic kidney disease-related events in adults with type 2 diabetes and chronic kidney disease (CKD). FLOW, semag...
The agreement The acquisition of the three production sites was announced on February 5. On May 29, Catalent shareholders voted in favor of the pending transac...
$Novo-Nordisk A/S (NVO.US)$
new
for some reason the profile says its lly
it's so greeen
Add...
No comment yet